Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Regulatory News (HAYD)

Share Price Information for Haydale (HAYD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.46
Bid: 0.45
Ask: 0.47
Change: 0.00 (0.00%)
Spread: 0.02 (4.444%)
Open: 0.46
High: 0.46
Low: 0.46
Prev. Close: 0.46
HAYD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Dealing

1 Dec 2015 12:05

RNS Number : 5744H
Haydale Graphene Industries PLC
01 December 2015
 

Haydale Graphene Industries plc

("Haydale" or the "Company")

 

Director Dealing

 

 

Haydale (AIM: HAYD), the group focused on the commercialisation of graphene and other nano particle products using its proprietary plasma process, announces that, on 1 December 2015, Ray Gibbs, Chief Executive, made the following transactions:

 

1. Exercise of 40,500 options under the 2013 Share Option Scheme to subscribe for a total of 40,500 ordinary shares of 2 pence each in the Company ("Ordinary Shares") at an exercise price of 92.5926 pence per share; and

 

2. Sale of 40,500 Ordinary Shares, at a price of 170.5 pence per share.

 

The sale proceeds will be used to fund, in part, the subscription of new shares by Ray Gibbs as outlined in the announcement on 2 November 2015.

 

Following the exercise of these options and disposal of shares, Mr. Gibbs' interest in the Company will remain unchanged at 469,929 Ordinary Shares representing 3.08% of the issued share capital of the Company.

 

Application has been made for the 40,500 Ordinary Shares to be admitted to trading on AIM and trading of these shares is expected to commence on or around 2 December 2015 ("Admission").

 

Following Admission, the Company has 15,236,946 Ordinary Shares in issue. The figure of 15,236,946 Ordinary Shares may be used by shareholders of Haydale as the denominator for the calculations to determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

 

- Ends -

 

 

For further information, please contact:

 

Haydale Graphene Industries plc

+44 (0) 1269 842 946

John Knowles, Chairman

Ray Gibbs, Chief Executive Officer

 

Cairn Financial Advisers LLP (Nomad)

+44 (0) 20 7148 7900

Tony Rawlinson

Emma Earl

 

Cantor Fitzgerald Europe (Broker)

+44 (0) 20 7894 7000

David Foreman, Will Goode (Corporate Finance)

David Banks, Tessa Sillars (Corporate Broking)

 

Hermes Financial PR

Trevor Phillips

Chris Steele

+44 (0) 7889 153 628

+44 (0) 7979 604 687

 

 

About Haydale (www.haydale.com)

Haydale has developed a patent pending proprietary scalable plasma process to functionalise graphene and other nanomaterials. This enabling technology can provide Haydale with a rapid and highly cost efficient method of supplying tailored solutions to enhance applications for both raw material suppliers and product manufacturers.

Functionalisation is carried out through a low pressure plasma process that treats both organic mined fine powder and other synthetically produced nanomaterial powders producing high quality few layered graphenes and graphene nano platelets. The process can functionalise with a range of chemical groups, where the amount of chemicals can be tailored to the customer needs. Good dispersion improves the properties and performance of the host material and ensures it delivers as specified.

The Haydale plasma process does not use wet chemistry, neither does it damage the material being processed, rather it can clean up impurities inherent in the raw material. The technology is a low energy user and most importantly environmentally friendly. The Haydale method is an enabling technology where working with a raw material producer can add value to the base product and tailor the outputs to meet the target applications of the end user.

Haydale, based in South Wales, housed in a purpose built facility for processing and handling nanomaterials with a laboratory facility, is facilitating the application of graphenes and other nanomaterials in fields such as inks, sensors, energy storage, photovoltaics, composites, paints and coatings.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBDBDDSGGBGUB
Date   Source Headline
7th Sep 20204:35 pmRNSPrice Monitoring Extension
20th Aug 20202:05 pmRNSSecond Price Monitoring Extn
20th Aug 20202:00 pmRNSPrice Monitoring Extension
20th Aug 202011:05 amRNSSecond Price Monitoring Extn
20th Aug 202011:00 amRNSPrice Monitoring Extension
19th Aug 202011:05 amRNSSecond Price Monitoring Extn
19th Aug 202011:00 amRNSPrice Monitoring Extension
18th Aug 20204:41 pmRNSSecond Price Monitoring Extn
18th Aug 20204:36 pmRNSPrice Monitoring Extension
14th Aug 20209:05 amRNSSecond Price Monitoring Extn
14th Aug 20209:00 amRNSPrice Monitoring Extension
20th Jul 20207:00 amRNSDistributor Agreement to Supply CeramycShield
14th Jul 20204:41 pmRNSSecond Price Monitoring Extn
14th Jul 20204:36 pmRNSPrice Monitoring Extension
14th Jul 20202:06 pmRNSSecond Price Monitoring Extn
14th Jul 20202:00 pmRNSPrice Monitoring Extension
13th Jul 20204:41 pmRNSSecond Price Monitoring Extn
13th Jul 20204:36 pmRNSPrice Monitoring Extension
9th Jul 20207:00 amRNSStock Appreciation Rights Plan and Warrant Deed
8th Jul 202011:00 amRNSPrice Monitoring Extension
6th Jul 20202:05 pmRNSSecond Price Monitoring Extn
6th Jul 20202:00 pmRNSPrice Monitoring Extension
6th Jul 202011:05 amRNSSecond Price Monitoring Extn
6th Jul 202011:00 amRNSPrice Monitoring Extension
3rd Jul 20202:05 pmRNSSecond Price Monitoring Extn
3rd Jul 20202:00 pmRNSPrice Monitoring Extension
1st Jul 20204:40 pmRNSSecond Price Monitoring Extn
1st Jul 20204:35 pmRNSPrice Monitoring Extension
1st Jul 202011:05 amRNSSecond Price Monitoring Extn
1st Jul 202011:00 amRNSPrice Monitoring Extension
1st Jul 20207:00 amRNSGraphene Enhanced Fabric for Antibacterial Masks
29th Jun 20207:00 amRNSDevelopment Agreement for Screen Printing Inks
10th Jun 202010:00 amRNSAppointment of Non-Executive Director
16th Apr 20207:00 amRNSTrading Update
8th Apr 202011:00 amRNSPrice Monitoring Extension
8th Apr 20209:05 amRNSSecond Price Monitoring Extn
8th Apr 20209:00 amRNSPrice Monitoring Extension
7th Apr 20207:00 amRNSDistributor Agreement
18th Mar 20202:05 pmRNSSecond Price Monitoring Extn
18th Mar 20202:00 pmRNSPrice Monitoring Extension
13th Mar 20203:24 pmRNSDirector/PDMR Shareholding
12th Mar 202011:55 amRNSDirector/PDMR Shareholding
9th Mar 20203:04 pmRNSDirector/PDMR Shareholding
9th Mar 20201:15 pmEQSHardman & Co Research: Haydale (HAYD): Cost savings continue, revenue growth encouraging
4th Mar 20202:05 pmRNSSecond Price Monitoring Extn
4th Mar 20202:00 pmRNSPrice Monitoring Extension
4th Mar 20207:00 amRNSiCraft Launch Graphene Cosmetic Face Mask
3rd Mar 20207:00 amRNSEnglish Institute for Sport Contract
27th Feb 20204:40 pmRNSSecond Price Monitoring Extn
27th Feb 20204:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.